Specialty
Boehringer Ingelheim specialty pioneering science inspired by patients we won’t rest until we can give people the chance to live the life they want.
EP.3: What are the Treatment Options for Patients with HP?
18/06/2024 | Author: Boehringer Ingelheim
Document ID: PC-TH-104748
RELATED CONTENT
2:54
FSIN||EP.7: The Future of Treatment for HP
2:40
FSIN||EP.6: The Experts’ Practical Experience with Nintedanib
3:27
